Embecta Corp. (EMBC)
USD 11.71
(-2.42%)
USD 11.71
(-2.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.21 Billion USD | 11.78% |
| 2022 | 1.08 Billion USD | 37.87% |
| 2021 | 788 Million USD | 6.78% |
| 2020 | 738 Million USD | -0.94% |
| 2019 | 745 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.19 Billion USD | -1.49% |
| 2024 Q1 | 1.21 Billion USD | 0.28% |
| 2024 Q3 | 1.26 Billion USD | 5.66% |
| 2023 Q1 | 1.19 Billion USD | 10.17% |
| 2023 FY | 1.21 Billion USD | 11.78% |
| 2023 Q4 | 1.21 Billion USD | -3.01% |
| 2023 Q3 | 1.25 Billion USD | 3.48% |
| 2023 Q2 | 1.21 Billion USD | 1.09% |
| 2022 Q4 | 1.08 Billion USD | 3.49% |
| 2022 Q2 | 833.5 Million USD | 12.65% |
| 2022 FY | 1.08 Billion USD | 37.87% |
| 2022 Q3 | 1.04 Billion USD | 25.95% |
| 2022 Q1 | 739.9 Million USD | -6.1% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 788 Million USD | 6.78% |
| 2021 Q4 | 788 Million USD | 0.0% |
| 2020 FY | 738 Million USD | -0.94% |
| 2019 FY | 745 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -1731.797% |
| Safety Shot Inc | 12.7 Million USD | -9455.298% |
| Bright Green Corporation | 17.4 Million USD | -6878.088% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -34.274% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -2015.016% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | -6.218% |
| Dynavax Technologies Corporation | 997.09 Million USD | -21.794% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -490.099% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -66.746% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 22.865% |
| PainReform Ltd. | 9.93 Million USD | -12129.607% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -4340.713% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -4340.713% |
| SCYNEXIS, Inc. | 128.41 Million USD | -845.706% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -5150.992% |
| Journey Medical Corporation | 76.84 Million USD | -1480.242% |
| Alpha Teknova, Inc. | 128.58 Million USD | -844.419% |
| Procaps Group, S.A. | 460.18 Million USD | -163.893% |
| Theratechnologies Inc. | 77.76 Million USD | -1461.548% |
| Harrow Health, Inc. | 311.75 Million USD | -289.537% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -8054.166% |
| Biofrontera Inc. | 27.93 Million USD | -4247.702% |
| DURECT Corporation | 45.18 Million USD | -2587.38% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 13.81% |
| Cronos Group Inc. | 1.13 Billion USD | -7.066% |
| OptiNose, Inc. | 107.72 Million USD | -1027.273% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -157.794% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -2070.548% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -5169.201% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -163.986% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -10089.478% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -1385.031% |
| Radius Health, Inc. | 1.71 Billion USD | 29.229% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -2178.978% |
| ProPhase Labs, Inc. | 91.92 Million USD | -1221.048% |
| Phibro Animal Health Corporation | 982.18 Million USD | -23.643% |
| Procaps Group S.A. | 460.18 Million USD | -163.893% |
| Alvotech | 950.09 Million USD | -27.819% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -2704.036% |
| Viatris Inc. | 47.68 Billion USD | 97.453% |
| Rockwell Medical, Inc. | 52.17 Million USD | -2227.641% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -928.325% |
| SIGA Technologies, Inc. | 254.83 Million USD | -376.541% |
| Tilray Brands, Inc. | 4.33 Billion USD | 71.988% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -343.694% |
| Shineco, Inc. | 84.17 Million USD | -1342.634% |
| PetIQ, Inc. | 868.22 Million USD | -39.871% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -14291.676% |
| Incannex Healthcare Limited | 17.04 Million USD | -7023.834% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 62.65% |
| Alimera Sciences, Inc. | 153.52 Million USD | -691.016% |
| Silver Spike Investment Corp. | 88.57 Million USD | -1271.022% |
| Assertio Holdings, Inc. | 286.41 Million USD | -323.994% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -20304.131% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -3493.346% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -3786.951% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -9066.986% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -365.063% |
| Hempacco Co., Inc. | 18.04 Million USD | -6630.558% |
| Talphera, Inc. | 20.39 Million USD | -5854.401% |
| Alvotech | 950.09 Million USD | -27.819% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -198.995% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 26.451% |
| Currenc Group, Inc. | 141.49 Million USD | -758.291% |
| Kamada Ltd. | 351.96 Million USD | -245.03% |
| Indivior PLC | 1.95 Billion USD | 37.763% |
| Evoke Pharma, Inc. | 7.06 Million USD | -17080.337% |
| Flora Growth Corp. | 23.62 Million USD | -5040.1% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -9066.986% |
| Evolus, Inc. | 188.99 Million USD | -542.546% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 5.108% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 19.731% |
| Akanda Corp. | 8.83 Million USD | -13637.567% |